Characterization of the large picornaviral polypeptides produced in the presence of zinc ion
- PMID: 4367904
- PMCID: PMC355513
- DOI: 10.1128/JVI.14.2.282-291.1974
Characterization of the large picornaviral polypeptides produced in the presence of zinc ion
Abstract
Zinc ion inhibits the posttranslational cleavages of human rhinovirus-1A, encephalomyocarditis virus, and poliovirus polypeptides. Each virus displayed a different susceptibility to zinc. However, in each case the cleavages of the capsid precursor and the cleavages analogous to the C --> D --> E conversion in encephalomyocarditis virus were most sensitive to zinc. Higher concentrations of zinc resulted in the buildup of even larger precursor polypeptides of a size between 106,000 and 214,000 daltons. The sizes of these polypeptides and the relative position of their gene loci on the viral RNA were determined. These data were used to place these polypeptides in the over-all scheme of viral protein processing.
Similar articles
-
A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus.Virology. 1973 Dec;56(2):439-53. doi: 10.1016/0042-6822(73)90048-2. Virology. 1973. PMID: 4357051 No abstract available.
-
Picornaviral gene order: comparison of a rhinovirus with a cardiovirus.J Virol. 1973 Feb;11(2):341-4. doi: 10.1128/JVI.11.2.341-344.1973. J Virol. 1973. PMID: 4347432 Free PMC article.
-
Virus-specific polypeptides in ascites cells infected with encephalomyocarditis virus.J Gen Virol. 1972 Nov;17(2):197-212. doi: 10.1099/0022-1317-17-2-197. J Gen Virol. 1972. PMID: 4344313 No abstract available.
-
Kinetics of synthesis and cleavage of encephalomyocarditis virus-specific proteins.Virology. 1972 Nov;50(2):535-49. doi: 10.1016/0042-6822(72)90405-9. Virology. 1972. PMID: 4344195 No abstract available.
-
Picornaviral structure and protein synthesis.Arch Int Physiol Biochim. 1976 Dec;84(5):1027-50. doi: 10.3109/13813457609069463. Arch Int Physiol Biochim. 1976. PMID: 65981 Review. No abstract available.
Cited by
-
Serum zinc levels in pediatric patients with COVID-19.Eur J Pediatr. 2022 Apr;181(4):1575-1584. doi: 10.1007/s00431-021-04348-w. Epub 2022 Jan 22. Eur J Pediatr. 2022. PMID: 35064310 Free PMC article.
-
Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury.Molecules. 2021 Oct 31;26(21):6614. doi: 10.3390/molecules26216614. Molecules. 2021. PMID: 34771023 Free PMC article. Review.
-
Zinc as a Neuroprotective Nutrient for COVID-19-Related Neuropsychiatric Manifestations: A Literature Review.Adv Nutr. 2022 Feb 1;13(1):66-79. doi: 10.1093/advances/nmab110. Adv Nutr. 2022. PMID: 34634109 Free PMC article. Review.
-
Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities.Br J Clin Pharmacol. 2021 Oct;87(10):3737-3746. doi: 10.1111/bcp.14826. Epub 2021 Jun 2. Br J Clin Pharmacol. 2021. PMID: 33742473 Free PMC article. Review.
-
A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients.J Med Virol. 2021 May;93(5):3261-3267. doi: 10.1002/jmv.26895. Epub 2021 Mar 9. J Med Virol. 2021. PMID: 33629384 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
